Efgartigimod led to statistically significant improvement in key symptoms of ocular myasthenia gravis compared with placebo in a phase 3 trial. Medscape Medical News
Tag: News
Trabeculectomy Often More Cost-Effective Than Tube Shunts
Analysis of data from a randomized trial finds trabeculectomy typically is the better financial bet than tube shunt surgery as a first option to treat glaucoma. Medscape Medical News
Are Visual Deficits After Stroke Being Missed?
The European Stroke Organization calls for systematic screening within days of stroke to detect visual deficits that affect up to three quarters of survivors. Medscape News Europe
Endophthalmitis a Risk for Years After Tube Shunt Surgery
The risk for endophthalmitis after glaucoma drainage rises for up to 5 years and is much higher than that for a device-placement surgery for detached retina, a study finds. Medscape Medical News
Study Backs Longer Compounded Lido Plus Epi Shelf Life
Research supports the safety and efficacy of compounded lidocaine plus epinephrine for up to 24 hours at room temperature and up to 7 days with refrigeration. Medscape Medical News
PET/CT Can Catch Cranial GCA Missed by Doppler Ultrasound
Digital FDG PET/CT can pick up cranial giant cell arteritis that may be missed on ultrasound because of a lack of trunk large-vessel involvement. Medscape Medical News
Ocular Therapeutix’s Eye Drug Superior to Regeneron’s Eylea in Late-stage Trial
Ocular Therapeutix said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision compared to Regeneron’s approved treatment… Reuters Health Information
Ocular Therapeutix Plunges as Modest Benefit Overshadow Trial Win Over Regeneron’s Eylea
Ocular Therapeutix’s experimental eye drug showed superiority to Regeneron’s Eylea in a key late-stage trial, but its modest advantage and higher rates of certain side… Reuters Health Information
New Rx Option for Neuromyelitis Optica Spectrum Disorder?
Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder. Medscape Medical News
Mary Tyler Moore Initiative Combats Diabetic Retinal Disease
Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate treatment. Medscape Medical News
What’s Good for the Heart Can Also Prevent Blindness
New research suggests that asymptomatic patients with significant risk factors for cardiovascular disease may also need to see an ophthalmologist. Medscape Medical News
UK Glaucoma Cases Set to Rise 60% by 2060, Study Warns
More than one million people in the UK may already have glaucoma, with cases projected to rise sharply by 2060, increasing demand for eye care services. Press Association
FDA Makes Ianalumab Breakthrough for Sjögren Disease
Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, contributing to this designation. Medscape Medical News
FDA Makes Ianalumab a Breakthrough Therapy for Sjögren’s
Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, contributing to this designation. Medscape Medical News
As Private Equity Sells Out, Will Eye Practices Fare Better?
PE ownership of ophthalmology practices has reshaped physician opportunities and patient care. Will things change with publicly held companies buying them out? Medscape Medical News
Eyeing Topical Options for Night Driving Problems
Impaired night vision affects 25 million Americans. Studies suggest topically reducing pupil size might help, especially for halo or starburst effects after refractive surgery. Medscape Medical News
US FDA Declines to Approve Outlook’s Eye Disease Drug for Second Time in 2025
Outlook Therapeutics said on Wednesday the U.S. health regulator has declined to approve its drug for a type of eye disease, dealing another blow in the company’s prolonged… Reuters Health Information
No Complications With First Human Robotic Cataract Surgery
A small proof-of-concept study of robotic-assisted cataract surgery reports successful outcomes with no treatment-related adverse events. Medscape Medical News
The 12 Dangers of Christmas
Echoing the 12 Days of Christmas, this festive guide outlines the seasonal risks clinicians can help patients avoid. Medscape News UK
Can a Visual Neuroprosthesis Communicate With the Brain?
A closed-loop cortical implant generates functional percepts of shape, motion, and letters in two individuals with acquired blindness. Medscape News Europe